Related Experiment Video
Updated: Jun 19, 2026

Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
[Epidemiologic study of Creutzfeldt-Jakob disease from autopsy-confirmed cases]
Yasushi Iwasaki1, Maya Mimuro, Mari Yoshida
1Department of Neurology, Oyamada Memorial Spa Hospital.
Insights
This study analyzed 61 sporadic Creutzfeldt-Jakob disease (CJD) cases in Japan, finding most patients were over 60 and predominantly had the Met/Met prion protein gene polymorphism. The research suggests a high autopsy rate for CJD in the Tokai region.
Area of Science:
- Epidemiology of prion diseases
- Neurodegenerative disorders
- Medical research methodology
Context:
- Creutzfeldt-Jakob disease (CJD) is a rare, fatal neurodegenerative disease.
- Understanding the epidemiology of sporadic CJD is crucial for public health.
- This study focuses on autopsy-confirmed sporadic CJD cases, excluding other forms.
Purpose:
- To investigate the epidemiologic characteristics of sporadic Creutzfeldt-Jakob disease (CJD) in the Tokai region of Japan.
- To analyze patient demographics, medical history, and genetic factors (prion protein gene polymorphism).
- To estimate the autopsy confirmation rate for CJD in the studied region.
Summary:
- The study examined 61 autopsy-confirmed sporadic CJD cases, with an average age of onset of 66 years.
- No significant differences in age of onset were observed between males and females.
- The majority of cases (92%) were homozygous for methionine at codon 129 (Met/Met) of the prion protein gene.
- Medical history revealed comorbidities like hypertension and diabetes, with a few cases having prior central nervous system operations.
- The study suggests a CJD autopsy rate exceeding 50% in the Tokai region over the past seven years.
Impact:
- Provides valuable data on the demographic and genetic profile of sporadic CJD patients in Japan.
- Highlights the importance of autopsy confirmation in diagnosing CJD.
- Contributes to understanding the geographical distribution and diagnostic practices for CJD in the Tokai region.
Abstract:
We investigated epidemiologic data from 61 cases of autopsy-confirmed sporadic Creutzfeldt-Jakob disease (CJD). Dura mater-associated CJD cases and familial CJD cases were excluded. There were 34 male and 27 female cases, with an average age at onset of 66.0 +/- 10.5 years (range 27 to 89). At onset of CJD, 1 case was aged in the 20's and 1 in 30's, but there were no cases aged in the 40's. In 6 cases, age at onset was in the 80's. There was no significant difference in relation to the age at onset between males and females, averaging 66.2 +/- 12.4 years (range 27 to 89), and 65.9 7.5 years (range 53 to 82), respectively. Two cases had been employed as medical workers (a medical technologist and a nurses' aide) but neither had an apparent history of contact with CJD patients. No cases in the study had either family history of CJD or apparent contact with CJD patients. Ten cases had a history of hypertension, 5 cases had a history of diabetes mellitus, 2 cases had a history of malaria and 1 case had suffered from atomic bomb exposure. Twenty-one cases had operation history, including 2 cases of an operation involving the central nervous system. One case had a skull-base fracture operation 19 years before the onset of CJD and the other case had an atlantoaxial subluxation operation 11 years before the onset of CJD; there was no transplantation of dura mater graft in either operation. There was one case with a history of conservative treatment for cerebral hemorrhage; this case had symptomatic secondary epilepsy as a coexisting disease at the onset of CJD. Two cases had Parkinson's disease as a coexisting disease at the onset of CJD. The source hospitals enforcing medical treatment were located in the Aichi (n = 42), Gifu (n = 12) and Mie (n = 7) prefectures of the Tokai region of Japan. Regarding patients' place of residence, 22 cases resided in Nagoya-city. Nagoya University Hospital performed the autopsy in 12 cases, but 10 cases of those were transported after death from the source hospital. Departments of neurology provided clinical treatment in 54 cases. Other departments that provided treatment were Internal Medicine (n = 3), Psychiatry (n = 2), Geriatrics (n = 1), and Neurosurgery (n = 1). In 39 cases, prion protein gene analyses using peripheral blood leukocyte or cryopreserved brain tissue were performed. As for polymorphic codon 129, 36 cases (92%) showed Met/Met, 3 cases showed Met/Val (8%) and no case showed Val/Val polymorphism. Polymorphic codon 219 showed Glu/Glu homozygosity in all of the examined cases. Active autopsy performance of CJD in the Tokai region was suggested from the present study. We estimated that the CJD autopsy rate of the district was more than 50% over the past 7 years.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Investigation of Disease Outbreaks
Cryptococcal Meningitis
Huntington Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

